Monday, July 10, 2023 Daily Archives

Canada calling: ramarketing cites life sci ecosystem in Toronto expansion

Marketing and communications agency ramarketing has opened an office in Toronto, Canada to tap the local life science talent and support the wider North American market. From its humble roots in Newcastle in the north-east of England in 2009, ramarketing has grown into an international marketing, design, digital, and content agency supporting the biopharma services and supply chain space. Having jumped across the pond in 2018 by setting up operations in Boston, Massachusetts, ramarketing is now strengthening its North American…

The King is dead? Humira biosimilars begin to flood the US

AbbVie’s Humira, the top selling drug of all time, now faces multiple threats in the US with the launch of a slew of adalimumab biosimilars. By the end of 2022, monoclonal antibody (mAb) Humira (adalimumab) had pulled in over $200 billion in sales for AbbVie (and previously Abbott) – more than any other drug. While biosimilars have tapped away at sales in Europe and outside the US for several years, the drug still pulled in $21.2 billion last year alone,…

Thermo Fisher to add data platform with $913m CorEvitas buy

Thermo Fisher is set to buy CorEvitas for $913 million, which will add real-world evidence solutions to its portfolio. Under the terms of the deal, Thermo Fisher Scientific will pay $912.5 million in cash for Massachusetts-based healthcare data provider CorEvitas. CorEvitas provides regulatory-grade, real-world evidence solutions to the biopharma space with an aim of improving patient care and clinical results. Subject to the deal closing, Thermo Fisher will add CorEvita’s data intelligence platform to its biopharma services unit and laboratory…

NewBiologix lauds Swiss ‘manpower’ to support CGT space

The educated workforce and high retention rates makes Switzerland a desirable place in the cell and gene therapy field, says NewBiologix.  Armed with $50 million in Series A funding, the recently launched Lausanne, Switzerland-based company, NewBiologix, is focused on rAAV vectors. The firm is developing a DNA-based platform for the advanced engineering of cell lines used to produce cell and gene therapies (CGT), which will be applied to human (HEK-293) and mammalian (CHO) cell lines. The firm has an operational…